Publication date: 21 March 2017
Source:Immunity, Volume 46, Issue 3
Author(s): Juan L. Mendoza, William M. Schneider, Hans-Heinrich Hoffmann, Koen Vercauteren, Kevin M. Jude, Anming Xiong, Ignacio Moraga, Tim M. Horton, Jeffrey S. Glenn, Ype P. de Jong, Charles M. Rice, K. Christopher Garcia
Type III interferons (IFN-λs) signal through a heterodimeric receptor complex composed of the IFN-λR1 subunit, specific for IFN-λs, and interleukin-10Rβ (IL-10Rβ), which is shared by multiple cytokines in the IL-10 superfamily. Low affinity of IL-10Rβ for cytokines has impeded efforts aimed at crystallizing cytokine-receptor complexes. We used yeast surface display to engineer a higher-affinity IFN-λ variant, H11, which enabled crystallization of the ternary complex. The structure revealed that IL-10Rβ uses a network of tyrosine residues as hydrophobic anchor points to engage IL-10 family cytokines that present complementary hydrophobic binding patches, explaining its role as both a cross-reactive but cytokine-specific receptor. H11 elicited increased anti-proliferative and antiviral activities in vitro and in vivo. In contrast, engineered higher-affinity type I IFNs did not increase antiviral potency over wild-type type I IFNs. Our findings provide insight into cytokine recognition by the IL-10R family and highlight the plasticity of type III interferon signaling and its therapeutic potential.
Graphical abstract
Teaser
Using an engineered high-affinity IFN-λ, Mendoza et al. solve the structure of the IFN-λ/IFN-λR1/IL-10Rβ ternary signaling complex. The structure reveals how IL-10Rβ can act as both a cross-reactive but cytokine-specific receptor. Structure-activity relationships of engineered type I and III IFNs provide insights into enhancing interferon functional potency.http://ift.tt/2mWiX6j
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου